BioAge Labs, Inc. (BIOA)
6.36
-0.25
(-3.78%)
USD |
NASDAQ |
Oct 05, 16:00
6.31
-0.05
(-0.79%)
After-Hours: 07:20
BioAge Labs EPS Diluted (Quarterly) : -0.582 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.582 |
| March 31, 2026 | -0.5238 |
| December 31, 2025 | -0.7185 |
| September 30, 2025 | -0.5626 |
| June 30, 2025 | -0.6015 |
| March 31, 2025 | -0.3606 |
| December 31, 2024 | -0.5894 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.6845 |
| June 30, 2024 | -0.3975 |
| March 31, 2024 | -0.3802 |
| December 31, 2023 | -0.6129 |
| September 30, 2023 | -0.4277 |
| June 30, 2023 | -0.503 |
| March 31, 2023 | -0.3244 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neumora Therapeutics, Inc. | -0.2327 |
| Alumis, Inc. | -1.114 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.10M |
| Revenue (Quarterly) | 2.451M |
| Total Expenses (Quarterly) | 28.55M |
| Enterprise Value | -24.77M |
| Gross Profit Margin (Quarterly) | 97.14% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -37.53% |
| Normalized Earnings Yield | -37.37 |